What is the Medpace Holdings Inc (MEDP) price today?

The price of Medpace Holdings Inc (MEDP) today is $395.7. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/MEDP

Buy & Sell Medpace Holdings Inc (MEDP) – Medpace Holdings Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

MEDP stock trades at $508.46, down 1.25% amid mixed signals. While Q1 2026 earnings beat expectations with EPS of $4.28 versus $3.92 expected and revenue grew 26.5% year-over-year to $706.6 million (Business Wire, 2026-04-22), the stock declined due to a booking miss overshadowing strong results. Valuation metrics show elevated multiples with P/E of 33.31 and P/S of 5.94, though profitability remains robust with net margin of 17.83% and ROE of 70.23%.

The outlook is clouded by multiple securities class action lawsuits alleging misleading growth projections (PRNewsWire, 2026-04-22), creating significant legal overhang. Analyst consensus is cautious with 71% hold ratings and a $504.17 price target slightly below current levels. While fundamental performance remains strong, legal risks and high valuation warrant careful monitoring for potential volatility.

Read full analysis

Key Stats

Market Cap
$14.53B
Sector
Technology
3M Drawdown
-34.67%
Enterprise Value
$14.15B
Dividend Yield
-
Trading Activity
70% Buy | 30% Sell
Typical Hold Time
0 days

$395.7

52W Low: $288.77

06 May 2025

52W High: $620.59

21 Jan 2026

Medpace Holdings Inc (MEDP) is currently valued at a market capitalization of $14.53B, with an enterprise value of $14.15B. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $288.77 and a high of $620.59, highlighting its annual price range. Over the past three months, Medpace Holdings Inc has recorded a drawdown of -34.67%, reflecting recent price volatility. On average, investors hold Medpace Holdings Inc for approximately 0 days, indicating typical investor behavior on the platform.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Technical Indicators

Overall Summary

Bearish (16)Neutral (9)Bullish (2)

News

Globe Newswire9 day ago

Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDP

Globe Newswire11 day ago

MEDP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit

Globe Newswire14 day ago

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Globe Newswire15 day ago

MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action lawsuit Filed Against Medpace Holdings Inc.

Globe Newswire16 day ago

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit – RGRD Law

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$14.53B
Sector
Technology
3M Drawdown
-34.67%
Enterprise Value
$14.15B
Dividend Yield
-
Trading Activity
70% Buy | 30% Sell
Typical Hold Time
0 days

$395.7

52W Low: $288.77

06 May 2025

52W High: $620.59

21 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell Medpace Holdings Inc (MEDP) – Medpace Holdings Inc Price Today

Aura AI Summary

Key Stats

About Medpace Holdings Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store